Biologická léčba X
LOTS
Show detail | ||||
---|---|---|---|---|
N006/19/V00019940/001 | I. Everolismus | Antineoplastika | Awarded | |
N006/19/V00019940/002 | II. Fingolimod | Imunosupresiva | Awarded | |
N006/19/V00019940/003 | III. Ruxolitinib | Antineoplastika | Awarded | |
N006/19/V00019940/004 | IV. Ranibizumab | Oftalmologika | Awarded | |
N006/19/V00019940/005 | V. Dabrafenib mesilat | Antineoplastika | Awarded | |
N006/19/V00019940/006 | VI. Lapatinib | Antineoplastika | Awarded | |
N006/19/V00019940/007 | VII. Pazopanib | Antineoplastika | Awarded | |
N006/19/V00019940/008 | VIII. Omalizumab | Léčivé přípravky pro onemocnění spojená s obstrukcí dýchacích cest | Awarded |